BioCryst Pharmaceuticals
BCRX
#4711
Rank
$2.28 B
Marketcap
$8.98
Share price
-2.81%
Change (1 day)
10.32%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -$0.46 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are $0.88 Billion USD. In 2025 the company made an earning of $0.26 Billion USD, an increase over its 2024 earnings that were of -$86.96 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.46 Billion-269.85%
2025 $0.26 B-407.51%
2024 -$86.96 Million-61.56%
2023 -$0.23 Billion-7.43%
2022 -$0.25 Billion34.42%
2021 -$0.19 Billion-0.55%
2020 -$0.19 Billion67.88%
2019 -$0.11 Billion7.55%
2018 -$0.11 Billion53.92%
2017 -$65.79 Million19.29%
2016 -$55.15 Million28.19%
2015 -$43.02 Million-4.8%
2014 -$45.19 Million50.09%
2013 -$30.11 Million-23.29%
2012 -$39.25 Million-26.19%
2011 -$53.18 Million54.78%
2010 -$34.36 Million150.1%
2009 -$13.74 Million-49.43%
2008 -$27.17 Million14.07%
2007 -$23.82 Million-49.31%
2006 -$46.98 Million72.87%
2005 -$27.18 Million22.08%
2004 -$22.27 Million75.3%
2003 -$12.7 Million-25.36%
2002 -$17.02 Million225.05%
2001 -$5.24 Million-56.6%
2000 -$12.07 Million50.63%
1999 -$8.01 Million38.05%
1998 -$5.8 Million-52.46%
1997 -$12.2 Million58.44%
1996 -$7.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
$10.72 B-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$10.01 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$24.46 M-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$78.05 M-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$64.46 Million-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.31 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-$8.1 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-$22.2 Million-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$59.1 M-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA